Year: 2026
Type: article
Abstract: In April 2024, the Royal Society convened a Science+ meeting in London on 'Vaccines and antimicrobial resistance: from science to policy'. The purpose was to review the science of how vaccines reduce antimicrobial resistance (AMR) and discuss policy in advancing development and equitable deployment of such vaccines. The meeting adopted a One Health approach with international speakers presenting from both human and veterinary perspectives. Presentations on Day 1 focused on scientific aspects of the AMR threat and the role of vaccines as counter measures. On Day 2, presentations covered associated policy implications based on this scientific understanding. A closing panel discussion looked towards the United Nations High-Level Meeting on AMR in New York in September 2024. This article is the closing contribution to an issue of Philosophical Transactions of the Royal Society B based on the meeting. It serves as a summary of the two days of proceedings, including key outcomes and recommendations, and provides an overall conclusion to the meeting. This article is part of the Royal Society Science+ meeting issue 'Vaccines and antimicrobial resistance: from science to policy'.
Authors: Calman A. MacLennan, Mateusz Hasso-Agopsowicz, Kelvin M. Abuga, Richard A. Adegbola, Annaliesa S. Anderson, Peter Borriello, Ed Buurman, Megan E. Carey, Mwelwa Chibuye, Duncan J. Colquhoun, Rory Cooney, Frédéric Descamps, Gordon Dougan, David C. Kaslow, Terry W. Komo, Richard Hatchett, William P. Hausdorff, Roberto La Ragione, Renée Larocque, Ramanan Laxminarayan, Anthony McDonnell, Katherine O'Brien, Laura M.A. Oliveira, Farah N. Qamar, Rino Rappuoli, Marta Tufet, Erica Westwood, Javier Yugueros-Marcos, Sally C. Davies
Institutions: University of Oxford, University of Birmingham, World Health Organization, Kenya Medical Research Institute, KEMRI-Wellcome Trust Research Programme, Nigerian Institute of Medical Research, Pfizer (United States), Food Standards Agency, Boston University, London School of Hygiene & Tropical Medicine, Amsterdam Institute for Global Health and Development, MMGH Consulting (Switzerland), Centre for Infectious Disease Research in Zambia, Norwegian Veterinary Institute, Veterinary Medicines Directorate, Zoetis (Belgium), University of Cambridge, United States Food and Drug Administration, Coalition for Epidemic Preparedness Innovations, Coalition for Epidemic Preparedness Innovations, University of Surrey, International Development Research Centre, International Development Research Centre, Center for Global Development, Fundação Oswaldo Cruz, Aga Khan University, Aga Khan University, Gavi, International Centre for Antimicrobial Resistance Solutions, World Organisation for Animal Health, Organisation Mondiale de la Santé Animale, Department of Health and Social Care
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7130512563